Advertisement

Brain and Cerebrospinal Fluid Quinolinic Acid Concentrations in Patients with Intractable Complex Partial Seizures

  • M. P. Heyes
  • A. R. Wyler
  • O. Devinsky
  • J. A. Yergey
  • S. P. Markey
  • N. S. Nadi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 294)

Abstract

Excitatory amino acids have been implicated in development and maintenance of seizures (Anderson et al., 1987; Meldrum 1987). In accordance with this notion are the observations that antagonists of excitatory amino acid receptors, including the NMDA receptor, are potent anticonvulsants (Meldrum et al., 1988). In the widely used model of kindling, electrophysiologic studies have demonstrated an increased sensitivity of NMDA receptors at stages IV and V (Mody et al., 1988). In man, increases in the concentrations of glutamate and aspartate, but not of GABA, have been reported in the focal compared to non-focal regions of cerebral cortex (Nadi et al., 1987; Sherwin et al., 1988). Additional studies have shown an increased number of NMDA receptors in the epileptic focus (Wyler et al., 1987). Studies in experimental animals have shown that local application of quinolinic acid (QUIN) increases neuronal activity (Perkins and Stone, 1983) and may cause seizures (Lapin, 1982). Conceivably, QUIN may therefore contribute to increased neuronal excitability in human seizure disorders. Direct measures of QUIN in human epilepsy have not been reported, although decreases in the degradative enzyme of QUIN, quinolinic acid phosphoribosyltransferase (QPRT), have been published (Feldblum et al., 1988), possibly indicating an impaired ability to catabolize QUIN.

Keywords

NMDA Receptor Excitatory Amino Acid Quinolinic Acid Complex Partial Seizure Epileptic Focus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Anderson, W.W., Swartzwelder, H.S., and Wilson, W.A., 1987, The NMDA receptor antagonist 2-amino-5-phosphonovalerate blocks stimulus train-induced epi-leptogenesis but not epileptiform bursting in the rat hippocampal slice, J. Neurophysiol., 57: 1–21.PubMedGoogle Scholar
  2. Feldblum, S., Rougier, A., Loiseau, H., Loiseau, P., Cohadon, F., Morselli, P.L., and Lloyd, K.G., 1988, Quinolinic acid phosphoribosyltransferase activity is decreased in epileptic human brain tissue, Epilepsia, 29: 523–529.PubMedCrossRefGoogle Scholar
  3. Gál, E.M., and Sherman, A.D., 1980, L-Kynurenine: its synthesis and possible regulatory function in brain, Neurochem. Res., 5: 223–239.PubMedCrossRefGoogle Scholar
  4. Heyes, M.P., Kim, P., and Markey, S.P., 1988, Systemic lipopoly saccharide and pokeweek mitogen increase quinolinic acid content of mouse cerebral cortex, J. Neurochem., 51: 1946–1948.PubMedCrossRefGoogle Scholar
  5. Heyes, M.P., and Markey, S.P., 1988a, [18O]-Quinolinic acid: its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid, 1., 15: 291–293.Google Scholar
  6. Heyes, M.P., and Markey S.P., 1988b, Quantification of quinolinic acid in rat brain, whole blood and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations, Anal. Biochem., 174: 349–359.PubMedCrossRefGoogle Scholar
  7. Lapin, I.P., 1982, Convulsant action of intracerebroventricularly administered L-kynurenine sulphate, quinolinic acid and other derivatives of suc-cinic acid, and effects of amino acids: structure-activity relationships, Neuropharmacology, 21: 1227–1233.PubMedCrossRefGoogle Scholar
  8. Meldrum, B., 1987, Neurotransmitter amino acids in epilepsy, Electroencephalogr. Clin. Neurophysiol. Suppl., 39: 191–199.PubMedGoogle Scholar
  9. Meldrum, B., Millan, M., Patel, S., and de Sarro, G., 1988, Antiepileptic effects of focal micro-injection of excitatory amino acid antagonists, J. Neural Transm., 72: 191–200.PubMedCrossRefGoogle Scholar
  10. Mody, I., Stanton, P.K., and Heinemann, U., 1988, Activation of N-methyl-D-aspartate receptors parallels changes in cellular and synaptic properties of dentate gyrus granule cells after kindling, J. Neurophysiol., 59: 1033–1054.PubMedGoogle Scholar
  11. Nadi, N.S., Wyler, A.R., and Porter, R.J., 1987, Amino acids and catechol-amines in the epileptic focus from the human brain, Neurology, Suppl., 37: 106.CrossRefGoogle Scholar
  12. Perkins, M.N., and Stone, T.W., 1983, Pharmacology and regional variations of quinolinic acid evoked excitations in rat central nervous system, J. Pharmacol. Exp. Ther., 226: 551–557.PubMedGoogle Scholar
  13. So, N., Oliver, A., Andermann, F., Gloor, P., and Quesney, L.F., 1989, Results of surgical treatment in patients with bitemporal epileptiform abnormalities, Ann. Neurol., 25: 432–439.PubMedCrossRefGoogle Scholar
  14. Sherwin, A., Robitaille, Y., Quesney, F., Olivier, A., Villemure, J., Leblanc, R., Feindel, W., Andermann, E., Gotman, J., Andermann, F., Ethier, R., and Kish, S., 1988, Excitatory amino acids are elevated in human epileptic cerebral cortex, Neurology, 38: 920–923.PubMedCrossRefGoogle Scholar
  15. Wyler, A.R., Nadi, N.S., and Porter, R.J., 1987, Acetylcholine, GABA, benzo-diazepine, glutamate receptors in the temporal lobe of epileptic patients, Neurology, Suppl., 37: 103.Google Scholar
  16. Young, S.N., Joseph, M.H., and Gauthier, S., 1983, Studies of kynurenine in human cerebrospinal fluid: lowered levels in epilepsy, J. Neural Transm., 58: 193–204.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • M. P. Heyes
    • 1
  • A. R. Wyler
    • 2
  • O. Devinsky
    • 3
  • J. A. Yergey
    • 4
  • S. P. Markey
    • 1
  • N. S. Nadi
    • 5
  1. 1.Laboratory of Clinical Science NIMHSection on Analytical BiochemistryBethesdaUSA
  2. 2.Department of NeurosurgeryUniversity of Tennessee School of MedicineMemphisUSA
  3. 3.UMDNJNewarkUSA
  4. 4.Laboratory of Clinical Studies NIAAASection of Analytical ChemistryBethesdaUSA
  5. 5.NINDSSection of Neuronal ExcitabilityBethesdaUSA

Personalised recommendations